Purpose The purpose of this retrospective study was to identify the impact of oral
anticoagulants on epistaxis with the focus on new oral anticoagulants. Methods The study …

Objectives Treatment of epistaxis in patients on anticoagulants is challenging and
associated with higher admission rates and longer hospital stays compared with patients …

Objective/Hypothesis Anticoagulant and antiplatelet medications (ACAP) are known to be
associated with an increased risk for epistaxis. There are conflicting results regarding the …

Background Epistaxis is one of the more common reasons for emergency room visits. The
main risk factor for epistaxis is anticoagulant therapy. Until recently, the main culprit was oral …

Objectives To assess any differences in severity and management of epistaxis when
complicating treatment by anti-vitamin K (AVK) or by new oral anticoagulants (NOAC) …

Objectives/Hypothesis To describe the characteristics and severity of epistaxis in patients
taking factor Xa inhibitors novel anticoagulants. Study Design Retrospective cohort study …

Objectives: Epistaxis can be caused or exacerbated by anticoagulant and antiplatelet
therapy. This prospective study assessed the prevalence of epistaxis in patients taking …

There is limited guidance available to clinicians regarding the management of
antithrombotic therapy during epistaxis, whilst there has been an increase in the use of …

Background and objectives: There is currently little published guidance on the management
of anticoagulant and antiplatelet medication in patients admitted with epistaxis. The routine …

Epistaxis in the anticoagulated patient poses a complicated management problem, which
requires interdisciplinary collaboration. The aetiology of the majority of cases of epistaxis …